Poland to produce Novavax coronavirus vaccine

Mabion, a Polish biotech company, will manufacture a Covid-19 vaccine under a licence with US pharmaceutical firm Novavax. Mabion has signed a deal with Novavax for the transfer of technology and technological trials in the manufacture of an antigen for Novavax's Covid-19 vaccine which is yet to be approved by the EU's medical agency, Mabion said in a statement on Wednesday.